Tissue-engineered grafts may be useful in Anterior Cruciate Ligament (ACL) repair and provide a novel, alternative treatment to clinical complications of rupture, harvest site morbidity and biocompatibility associated with autografts, allografts and synthetic grafts. We successfully used supercritical carbon dioxide (Sc-co 2) technology for manufacturing a "smart" biomaterial scaffold, which retains the native protein conformation and tensile strength of the natural ACL but is decellularized for a decreased immunogenic response. We designed and fabricated a new scaffold exhibiting (1) high tensile strength and biomechanical properties comparable to those of the native tissue, (2) thermodynamically-stable extra-cellular matrix (ECM), (3) preserved collagen composition and crosslinking, (4) a decellularized material milieu with potential for future engineering applications and (5) proven feasibility and biocompatibility in an animal model of ligament reconstruction. Because of the "smart" material ECM, this scaffold may have the potential for providing a niche and for directing stem cell growth, differentiations and function pertinent to new tissue formation. Sc-CO 2-related technology is advanced and has the capability to provide scaffolds of high strength and durability, which sustain a lifetime of wear and tear under mechanical loading in vivo. The anterior cruciate ligament (ACL) is the most frequently injured ligament in the knee. More than 200,000 patients are diagnosed yearly with ACL disruptions 1,2 and approximately 120,000 ACL reconstructions are performed annually in the United States 3. Because it receives nourishment mainly from the surrounding synovial fluid, the ACL has poor natural healing ability and thus necessitates surgical reconstruction when ruptured 4. Primary surgical repair of ligaments has shown poor results in clinical practice and is not commonly used as a treatment option today 5. Since the reconstructed knees need to last the lifetime of the patient, the repaired ligament needs to possess reliable durability under the body's mechanical loading and active stress during daily activities. This requirement translates into the need for a biomechanically and biologically stable replacement that must withstand a lifetime of wear and tear. Historically, the medical field has explored various approaches in search of the perfect tissue substitute for the natural ACL. Autografts, which involve reconstruction using the patient's own tendons to replace the damaged ACL, have offered good strength and served as successful surgical substitutes in 85-90% of clinical cases 6. However, autograft harvesting causes significant donor site morbidity, including anterior knee pain, patellar tendinitis, and infra-patellar contracture, following the harvesting of the patellar tendon; hamstring weakness, and saphenous nerve injury after harvesting of the hamstring tendons 7. Synthetic materials have been extensively studied as replacements of the native ACL 8,9. These synthetic substitutes have generally exhibite...